Company Filing History:
5 out of 2,123 
1 out of 65 
1 out of 7 Years Active: 2006-2013
Title: Thomas E Adrian: Innovator in Antitumor Agents
Introduction
Thomas E Adrian is a prominent inventor based in Chicago, IL (US), known for his significant contributions to the field of antitumor agents. With a total of 6 patents, Adrian has focused his research on cyclic peptide compounds that exhibit antitumor activity against various types of cancer.
Latest Patents
Among his latest patents, Adrian has developed cyclic peptide compounds and derivatives that demonstrate antitumor activity, particularly in the treatment of human melanoma, pancreatic, breast, and prostate cancer cells. These innovative compounds hold promise for advancing cancer treatment and improving patient outcomes.
Career Highlights
Throughout his career, Thomas E Adrian has worked with esteemed institutions such as Northwestern University and Creighton University. His research has contributed to the understanding and development of effective cancer therapies, showcasing his dedication to scientific advancement.
Collaborations
Adrian has collaborated with notable colleagues, including Richard B Silverman and Shouxin Liu, further enhancing the impact of his work in the field of cancer research.
Conclusion
In summary, Thomas E Adrian is a distinguished inventor whose work in cyclic peptide antitumor agents has the potential to revolutionize cancer treatment. His innovative research and collaborations continue to pave the way for advancements in medical science.